You are here: Industry Insights > vaccine

News List

Two billion doses of AstraZeneca’s COVID-19 vaccine supplied to countries across the world WorldPharmaNews
November 17, 2021
AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the last 11 months.
Alcami Inks Lab Services Agreement with Novavax ContractPharma
November 17, 2021
Alcami, a U.S.-based CDMO, has signed a master laboratory services agreement with Novavax, a biotechnology company developing next-generation vaccines for infectious diseases.
NII says Covaxin has cellular immune memory to COVID for at least six months ExpressPharma
November 17, 2021
Covaxin has immunological memory to SARS-CoV-2 and its variants of concern for at least up to six months, Pushkar Sharma, Director in-Charge, National Institute of Immunology (NII) said...
Prior SARS-CoV-2 Infection Ups Protection for Vaccinated Drugs
November 16, 2021
For individuals vaccinated with mRNA COVID-19 vaccines, prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a lower risk for breakthrough infection...
AstraZeneca to transition to ‘modest profitability’ on future COVID-19 vaccine orders CPhIonline
November 16, 2021
AstraZeneca will start to receive a modest profit from its COVID-19 vaccine as part of a post-pandemic commercial approach, the Anglo-Swedish drugmaker announced at a press conference on Friday.
Johnson & Johnson COVID-19 vaccine named one of Time's Best Inventions of 2021 WorldPharmaNews
November 15, 2021
The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021.
Estimated Coverage With Measles Vaccine Down in 2020 Drugs
November 15, 2021
The estimated measles-containing vaccine first dose (MCV1) coverage increased globally to a peak in 2019, then decreased in 2020, according to research published in the Nov. 12 issue...
Bharat Biotech MD says Ideal time for COVID booster shot is six months after second dose ExpressPharma
November 12, 2021
The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Krishna Ella, Chairman and Managing Director, Bharat Biotech, said yesterday...
Nearly 900,000 U.S. Children Under 12 Have Gotten Their First COVID-19 Shot Drugs
November 11, 2021
About 900,000 U.S. children aged 5 to 11 years received their initial dose of the Pfizer COVID-19 vaccine during the first week of eligibility for that age group, the Biden administration said Wednesday.
New protein-based COVID vaccine doesn’t need cold storage: Study ExpressPharma
November 09, 2021
Scientists have developed a new protein-based vaccine candidate for COVID-19 that they say is much easier to produce and does not need refrigeration.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page